Research

Found 6 results

Sort by: Author Title [ Year (Desc)]
Filters: Author is JT McCracken  [Clear All Filters]
2009
King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD, Donnelly CL, Anagnostou E, Dukes K, Sullivan L et al..  2009.  Lack of Efficacy of Citalopram in Children with Autism Spectrum Disorders and High Levels of Repetitive Behavior. Archives of General Psychiatry. 66(6):583-590.
2008
Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A et al..  2008.  Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior. Journal of Child and Adolescent Psychopharmacology. 18(3):227-236.
2007
Flanders SC, Engelhart L, Pandina GJ, McCracken JT.  2007.  Direct Health Care Costs for Children with Pervasive Developmental Disorders: 1996-2002. Adm Policy Ment Health & Ment Health Serv Res. 34(3):213-220.
Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ et al..  2007.  Effects of Short- and Long-Term Risperidone Treatment on Prolactin Levels in Children with Autism. Biol Psychiatry. 61(4):545-550.
2006
Lindsay RL, Arnold LE, Arnold MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L, Pachler M, McCracken JT, Tierney E et al..  2006.  Dietary Status and Impact of Risperidone on Nutritional Balance in Children with Autism: A Pilot Study. Journal of Intellectual & Developmental Disability. 31(4):204-209.
Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B et al..  2006.  A Prospective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 16(5):589-598.
Share |